Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 5 of 10« First...34567...10...Last »

Angola’s yellow fever death toll rises to 158: WHO

A yellow fever outbreak in Angola that began late last year has killed 158 people, up from 50 a month ago, as deaths from the disease transmitted by mosquitoes accelerate, a World Health Organisation official said on Friday. There has also been an increase in malaria, cholera and chronic diarrhea in Luanda and other cities, […]

Read More »

Omnis Pharma and Magnis Therapeutics Merge to Form Vyriad

ROCHESTER, Minn., March 18, 2016 /PRNewswire/ — Omnis Pharma, Inc. and Magnis Therapeutics, LLC, announced today their strategic merger to form Vyriad, a clinical-stage oncolytic immunovirotherapy development company. The combined companies’ product development pipeline encompasses multiple clinical-stage and late preclinical-stage products targeting a broad range of human cancer indications, including a Phase 1 development program partnered […]

Read More »

Seattle’s Adaptive Biotech to Base New Business in San Diego

Ex-Johnson &  Johnson exec Diego Miralles in charge of the new business as president     March 18, 2016By Alex Keown, Breaking News Staff   SEATTLE – Adaptive Biotechnologies tapped former Johnson & Johnson (JNJ) executive Diego Miralles as president of its new San Diego-based Adaptive Therapeutics division, which will focus on development of […]

Read More »

Investor Woodford calls for outsider to head GlaxoSmithKline

Fund manager Neil Woodford, a top investor in GlaxoSmithKline and a critic of the drugmaker’s current structure, said on Thursday he wanted to see an outsider replace Andrew Witty as the group’s chief executive.   “I have a strong preference for an external candidate,” Woodford said in an e-mailed statement. Britain’s biggest drugmaker said on […]

Read More »

Germany’s Bayer wins U.S. FDA approval for hemophilia A therapy

The U.S. Food and Drug Administration approved Bayer AG’s therapy for the most common form hemophilia, the company said on Thursday, about three weeks after the treatment was cleared for use in Europe. The therapy, Kovaltry, is designed to reduce bleeding in patients with hemophilia A when infused prophylactically two or three times per week, […]

Read More »

Amgen Wins Trial Against Regeneron and Sanofi for Cholesterol Drug Patents, Appeal Likely

Amgen announced yesterday that a jury in Delaware district court came down on the company’s side, defending two patents being contested by Sanofi and Regeneron Pharmaceuticals.

Read More »

San Francisco-Based McKesson Eliminates 1,600 U.S. Jobs to Trim Costs

March 17, 2016By Alex Keown, Breaking News Staff   SAN FRANCISCO – Faced with a need to trim costs, McKesson Corporation (MCK) will slash 1,600 jobs, about 4 percent of its U.S. workforce, in response to a loss of some key customers, Reuters reported this morning. In January, McKesson conducted a “strategic review” of […]

Read More »

GlaxoSmithKline CEO Witty to bow out in March 2017

GlaxoSmithKline said on Thursday its Chief Executive Andrew Witty would retire in 12 months time, after leading the British drugmaker through a series of changes since 2008 that have failed to ignite the share price.   Witty, a 31-year company veteran, has been under fire from some investors in the past three years as sales […]

Read More »

For New York hospital’s patients, miniature horses are a strong medicine

Some of the most powerful medicine delivered to young patients at Mount Sinai Hospital in New York on Wednesday came in a package less than 32 inches tall and with a tail. Honor, a 10-month-old colt with Gentle Carousel Miniature Therapy Horses, trotted into the hearts of dozens of children and teens being treated at […]

Read More »

The Evolving Role of Global Teams in a Digital World

Much has been written about the impact of digital media on the life sciences industry. However, an area less discussed is how to maximize that impact globally, and in particular how to organize for success.

Read More »

FDA warns India’s Emcure Pharma, cites repeated data fudging at plant

The U.S. Food and Drug Administration (FDA) has warned Indian generic drugmaker Emcure Pharmaceuticals, saying it repeatedly fudged test records at its plant in western India, in another case of a pharmaceutical firm in the country facing such action.   In a letter, the FDA said its staff inspected Emcure’s plant at Hinjwadi, Pune, where […]

Read More »

New technology chief joins Palio; Saratoga office to wind down

Changes are taking place at Palio. The agency will be shutting down its Saratoga, N.Y., office by the end of June and consolidating business in its New York City and Los Angeles offices. Additionally, the agency has appointed its first technology leader. As senior VP, director of technology, Bryan Roman will report to President Kim […]

Read More »

Study strengthens Zika-microcephaly link, women and babies at risk

Thousands of pregnant women caught in the outbreak of the mosquito-borne virus spreading from Brazil risk having a baby with the birth defect microcephaly, according to study results.

Read More »

Gilead Shuts Down Six Zydelig Trials Following EMA Review

Gilead Sciences halted six trials for its cancer drug Zydelig following concerns of adverse effects and deaths.

Read More »

E-Commerce: Its advancement and upcoming perspectives

The e-commerce could very well be described being a new home business methodology that addresses the demands of corporations, retailers, and people to chop expenses as bettering the standard of products and products and services and expanding the pace of company shipping and delivery, by utilizing The web. The event of electronic commerce evolved to […]

Read More »

UK’s Vectura Buys Skyepharma to Create Powerful Respiratory Company

Chippenham, UK-based Vectura Group plc announced that the company is acquiring Skyepharma plc of London in a deal worth $621 million.

Read More »

Allied-Bristol Life Sciences Launches ißeCa Therapeutics

Allied-Bristol Life Sciences announced a new subsidiary to license compounds from the NYU School of Medicine targeting the Wnt signaling pathway, which is implicated in various cancers.

Read More »

E-Commerce: Its growth and upcoming perspectives

The e-commerce tends to be outlined as the cutting-edge internet business methodology that addresses the specifications of companies, retailers, and people to cut expenses although increasing the standard of goods and solutions and boosting the velocity of program shipping, by making use of Internet. The development of digital commerce advanced as a means of growing […]

Read More »

E-Commerce: Its improvement and long term views

The e-commerce might be outlined like a modern-day industry methodology that addresses the needs of organizations, retailers, and customers to chop prices even while bettering the quality of products and services and expanding the pace of support shipping and delivery, by using Online world. The development of digital commerce evolved as being a strategy for […]

Read More »

Sanofi signs deal worth up to $2.3 billion with DiCE Molecules

French drugmaker Sanofi could pay privately held DiCE Molecules as much as $2.3 billion under a partnership deal announced on Wednesday that aims to find new oral medicines to replace injections for certain diseases.   The five-year research alliance involves Sanofi paying an initial $50 million to access DiCE’s technology and taking an equity stake […]

Read More »

Page 5 of 10« First...34567...10...Last »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom